Our Company, Our Values, and a Key Proposition
Our three-year vision (2028): Modernize 1,000 ORs for the wireless era.
Meet Team Lazurite.
Our Mission
Solve impossible problems to improve people’s lives
We pursue success and satisfaction by:
- Dedicating ourselves to better outcomes for all participants in the healthcare system.
- Forging authentic, meaningful relationships.
- Working diligently and collaboratively to foster moments of serendipity.
Our Company
Dr. Mark Froimson is the Chair and CEO of Lazurite and principal of Riverside Health Advisors, specializing in financing and accelerating healthcare innovation. He serves as chief medical officer for AngelMD, chairs the boards of Lazurite and Thrive, and is a board member for Pacira Biosciences, Inc., Sintx Technologies, Inc., and several nonprofits, including the Arthritis Foundation.
Mr. Eugene Malinskiy is one of our co-founders (est. 2015) and our Chief Technology and Product Officer. Prior to Lazurite, he served as the founder and CEO of DragonID, LLC, a healthcare innovation and engineering consultancy specializing in medical devices for orthopedics and cardiology.
Ms. Leah Brownlee joined our company in her current roles in October 2020. She currently serves as board chair of Switch Automation (US), Inc. and her previous positions include of counsel in the global corporate department at Squire Patton Boggs (US) LLP, a top-20 global law firm and executive vice president of compliance and operations at Cleveland Biolabs (NASDAQ: CBLI).
Mr. Neil Lyons joined our company in June 2023. He started his career with Deloitte and practiced as a CPA with them for more than 10 years. From 2005 to 2021, Neil served as the CFO for three life science companies, two public and one private. Since then, Mr. Lyons has worked with life science companies on a fractional basis.
Mr. Jerry Deluca joined Lazurite in February 2024. His other roles include managing partner at Vergil Ventures and distinguished venture partner at NextGen Venture Partners, where he has served as a key figure in healthcare innovation. With his extensive leadership experience at companies such as Arthrex and Intuitive Surgical, Jerry brings a wealth of strategic insights to bear on the intricacies of the ever-evolving, health-tech sector.
Mr. Dan Nelson joined our company as Director of Product Development in 2018 and moved to his current role in 2022. His previous positions include senior product manager at Volk Optical Inc. where he managed a non mydriatic retinal camera and drove development of an imaging platform, and program manager at DXY Solutions, LLC where he lead development of applications for dozens of companies. Mr Nelson served our country as a sergeant in the US Air Force.
Mr. Patrick Polito, a certified quality auditor, joined our company in 2016. His previous positions include manager of client services at iuvo BioScience, microbiologist, and validation specialist. He has spent many years in both client and regulatory agency facing positions.
Our Medical Advisors
Dr. Jazrawi is chief of the sports medicine division at NYU Langone Health, as well as the team physician for NYU athletics and Long Island University athletics. He specializes in the surgical management of sports injuries, and has substantial experience in the care of pitchers in particular, and other athletes with injuries due to overhead throwing.
Laith Jazrawi, MD
NYU Langone Health
Dr. Proctor is an orthopaedic surgeon at De La Vina Surgicenter. His previous roles include stadium physician for the New York Yankees, as well as consulting physician for the US Ski Team and UC Santa Barbara athletics. He has developed and patented devices that prevent and rehabilitate sports injuries, and his current research includes novel techniques to repair shoulders and knees.
Christopher Proctor, MD
De La Vina Surgicenter
Dr. Schickendantz is program director of orthopedic surgery for the Cleveland Clinic Sports Health. He is also the head team physician of the Cleveland Guardians. His specialties include sports medicine and arthroscopic surgery of the shoulder and elbow. His memberships include the American Board of Orthopedic Surgery and the MLB Team Physicians Association.
Mark Schickendantz, MD
The Cleveland Clinic
Dr. Voos currently serves as chair of the orthopedics departments at University Hospitals and Case Western Reserve University, which includes overseeing their renowned orthopedic training programs and research divisions. He was recently elected vice president of the NFL® Physicians Society and serves as the team physician for the Cleveland Browns™.
James Voos, MD
University Hospital (CLE)
Our Board
Dr. Mark Froimson is the principal of Riverside Health Advisors, specializing in healthcare innovation. He serves as chief medical officer for AngelMD and chairs the boards of Lazurite and Thrive. Additionally, he sits on the boards of Pacira Biosciences, Inc., Sintx Technologies, Inc., and the Arthritis Foundation, while advising various healthcare provider and technology companies.
As executive vice president and chief clinical officer for Trinity Health, Dr. Froimson managed physician, nursing and pharmacy services, quality, safety, patient experience and alternate payment strategies for the clinical enterprise. For 16 years, he was a member of the faculty of the Department of Orthopedic Surgery at the Cleveland Clinic. During that time, he served as president and CEO of Cleveland Clinic’s Euclid Hospital, president of the professional staff of the Cleveland Clinic, vice chair of the Orthopedic and Rheumatologic Institute, and as a member of the Board of Governors and Board of Trustees.
Mark Froimson, MD
Chair and CEO
Mr. Gary Cohn is the vice chairman of IBM and former director of the U.S. National Economic Council. He served as assistant to President Trump for economic policy, coordinating the economic agenda and leading the passage of the Tax Cuts and Jobs Act of 2017. Prior to this, Mr. Cohn had a notable career at Goldman Sachs, where he was global co-head of the equities and fixed income division and president and COO.
Gary Cohn
Mr. Jeff Hanson has over 30 years of financial and advisory experience. As the founder of Hanson Advisors, he partners with businesses in financial services, private equity, and healthcare, helping teams achieve success through transitions. He was a founding member of Milestone Capital Management and, at Goldman Sachs, developed innovative consulting solutions to drive growth across banking, sales, trading, and operations.
Jeff Hanson
Mr. Michael Salerno has over 20 years of experience in family wealth and investment management. He is the managing partner of AUA Capital Management, which he co-founded in 2013. Previously, he was managing director at QFS Asset Management and co-founded Cenario Capital Management. Mr. Salerno also served as CIO for the Unanue Family Office and the founding managing director for Select Trust and Asset Management, and was president of M&T Capital, the venture subsidiary of M&T Bank.
Michael Salerno
Jon Serbousek is the CEO and Director of Corin Group, with over 30 years of experience in med device and biotech. Previously, he served as president and CEO of Orthofix and held leadership roles at Biomet, Medtronic, and DePuy Orthopedics. His expertise spans orthopedics, spine, and biologics, having led global divisions and product development teams.
Jon Serbousek
Mr. Malinskiy is a serial entrepreneur and the Founder, Chief Technology and Product Officer of Lazurite, where he leads product strategy and innovation. After selling his first company in 2008, he founded DragonID, a biomedical engineering consultancy. Recognized for his achievements, Mr. Malinskiy was named to Forbes’ 30 Under 30 in Manufacturing in 2015 and has earned accolades from Inside Business and Crain’s Cleveland Business for his innovative work.
Eugene Malinskiy
Co-founder and CTPO
Our Philosophy
We established Lazurite to build operating room technology commensurate with the skills of clinicians, in order to improve patient outcomes, boost clinical safety, and improve healthcare efficiency.
To meet these goals, we organize our work around six core values.
01
People first.
We focus on problems in healthcare (not just the healthcare market). We use science, engineering, and design to build durable, substantial solutions. Our rigorous solutions open opportunities in the market.
02
Be present.
Every interaction with an investor, vendor, or partner represents an opportunity to bolster faith in our vision. We take the time to tell our story well, and build personal connections at every opportunity.
03
Be open. Be receptive.
We recognize the need to think anew about persistent challenges, and to seek out creative connections that spark new ideas on the way to serendipitous solutions.
04
Do what it takes, together.
There is no substitute for hard work—or teamwork. We ask each other difficult questions. We connect the dots together, and we celebrate our triumphs together.
05
Some things are not possible, yet.
Through creativity, diligence, and collaboration, we can narrow the gap between today, when a goal is impossible, and the moment it becomes possible.
06
Reliability equals sustainability.
When we say what we mean and deliver the goods, we ensure that we, as a company, thrive.
How We Work
We know surgeons.
They are our stakeholders and our inspiration. Where they see inefficiencies, we see opportunities.
We listen, observe, and integrate.
Our team is our foundation. We work diligently and inclusively to identify areas for transformative improvements.
We solve.
Our engineers plan, prototype, test, and repeat. We develop solutions that are as simple as possible, but no simpler.
We influence people.
We deliver value by design to providers and patients. Our mission is to drive better people outcomes.
Our Dedication to Quality
Our team pursues engineering excellence through its embrace of quality standards. Our quality policy reflects our work philosophy:
We are committed to providing safe and effective products that improve the quality of life for the people we serve.
We are dedicated to continuously improving the effectiveness of our quality management systems, products, and services by meeting customer expectations and regulatory requirements.
Our commitment to quality is reflected by our partners. Our products are designed, manufactured, and tested to ensure that they meet the quality standards the medical device industry demands. We have implemented processes compliant with ISO 13485, the medical industry’s quality management standard. Likewise, we expect our critical partners and manufacturers to also follow ISO 13485 requirements. Lazurite is certified bi-annually by the global certification body NQA.
Compliance and Ethics
Integrity
Ethics and integrity are key to establishing and maintaining trust. We know that in medtech, though, the pressure to move fast can strain—or even break—the bonds of trust.
At Lazurite, we aim to maintain a standard of open, honest communication and a steadfast commitment to legal and ethical conduct. We invite our employees to provide each other with in-person feedback on experimental design, data integrity, and reliable sources for marketing claims, to begin. This conduct includes our interactions and transactions with our customers, employees, suppliers, partners, shareholders, community, and competitors.
As part of this commitment, we have adopted the AdvaMed Code of Ethics.
The AdvaMed Code of Ethics provides medical technology companies with guidance on ethical interactions and relationships with healthcare professionals. It offers a blueprint for how to build trust among employees and, in turn, how employees can conduct themselves in a trustworthy manner with one of our key constituencies.
Partners and Collaborators
Tracy Wise and Maria Summers of CHAMPS GPO staff the Lazurite booth at AANA.
Partners
Collaborators
To know what’s next in agile surgical care, subscribe to our newsletter.
